Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Now, After all the discussion/research....

This topic was discussed a couple of weeks ago.  I remeber making the point then that it would/could be a waste of time and money to go all out with the PR blitz while there still remained a sizable obstacle in the way of significant share price appreciation - namely the warrant overhang.  Why not wait until that is out of the road so that effects of a PR campaign are not completely dampened by additional conversions/selling? 

Then again, I am of the opinion that we should not need a PR campaign to help bolster share price, rather the merits of the company itself and the financial performance thereof will do the job itself, in due course. 

 

Share
New Message
Please login to post a reply